2-isopropyl-5-(2-phenylethenyl)benzene-1,3-diol,
3,5-DH4IS,
3,5-dihydroxy-4-isopropylstilbene,
5-(2-phenylethenyl)-2-isopropyl-1,3-benzenediol,
benvitimod,
GSK2894512,
tapinarof,
WBI-1001,
Tapinarof,
Benvitimod,
79338-84-4,
3,5-Dihydroxy-4-isopropylstilbene,
WBI 1001,
WBI-1001,
GSK2894512,
UNII-84HW7D0V04,
(E)-2-(1-Methylethyl)-5-(2-phenylethenyl)-1,3-benzenediol,
84HW7D0V04,
(E)-2-isopropyl-5-styrylbenzene-1,3-diol,
5-[(E)-2-phenylethenyl]-2-propan-2-ylbenzene-1,3-diol,
1,3-Benzenediol, 2-(1-methylethyl)-5-[(1E)-2-phenylethenyl]-,
3,5-DH4IS,
Tapinarof [USAN],
AC1O5RUE,
AC1Q1OF9,
SCHEMBL918343,
CHEMBL259571,
GTPL9686,
BCP13569,
ZINC5761533,
(E)-4-Isopropylstilbene-3,5-diol,
MFCD13193203,
AKOS025296109,
SB18964,
WB-1001,
GSK-2894512,
AS-44364,
HY-109044,
CS-0031487,
2-(1-methylethyl)-5-[(E)-2-phenylethenyl]benzene-1,3-diol,
1,3-Benzenediol, 2-(1-methylethyl)-5-(2-phenylethenyl)-, (E)-,
DHPS,
C17-H18-O2,
CID6439522,